AT9283
- Generic Name
- AT9283
- Drug Type
- Small Molecule
- Chemical Formula
- C19H23N7O2
- CAS Number
- 896466-04-9
- Unique Ingredient Identifier
- XAV9KYN9WL
Overview
AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer. It was discovered and developed internally using Astex’s fragment-based drug discovery platform, Pyramid.
Background
AT9283 is an aurora Kinase inhibitor developed by Astex Therapeutics for the treatment of cancer. It was discovered and developed internally using Astex’s fragment-based drug discovery platform, Pyramid.
Indication
Investigated for use/treatment in cancer/tumors (unspecified), leukemia (myeloid), and solid tumors.
Associated Conditions
No associated conditions information available.
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath